ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 218 filers reported holding ACCELERON PHARMA INC in Q1 2020. The put-call ratio across all filers is 1.14 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $454,000 | -59.3% | 3,616 | -69.1% | 0.04% | -50.6% |
| Q2 2020 | $1,116,000 | +200.0% | 11,716 | +182.9% | 0.08% | +185.2% |
| Q1 2020 | $372,000 | +14.8% | 4,141 | -50.1% | 0.03% | +17.4% |
| Q1 2018 | $324,000 | +21.8% | 8,292 | +16.5% | 0.02% | -65.7% |
| Q3 2017 | $266,000 | -5.3% | 7,120 | -32.8% | 0.07% | +86.1% |
| Q1 2017 | $281,000 | -45.4% | 10,601 | -34.9% | 0.04% | -37.9% |
| Q2 2015 | $515,000 | – | 16,295 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
| Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
| Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
| Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
| Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
| QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
| Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
| Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |